We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+0.25%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$119B
AUM Growth
+$5.64B
Cap. Flow
+$6.41B
Cap. Flow %
5.41%
Top 10 Hldgs %
16.36%
Holding
4,406
New
331
Increased
2,055
Reduced
1,449
Closed
309

Sector Composition

Rank Sector Weight
1 Healthcare 11.59%
2 Technology 10.75%
3 Financials 9.31%
4 Consumer Discretionary 6.45%
5 Communication Services 5.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SAIL
751
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
$26.7M 0.02%
1,427,291
+123,593
+9% +$2.62M
GRUB
752
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
$26.6M 0.02%
236,667
+104,016
+78% +$13.8M
UHS icon
753
Universal Health Services
UHS
$10.2B
$26.6M 0.02%
178,598
-14,921
-8% -$2.14M
MPLX icon
754
MPLX
MPLX
$59.3B
$26.5M 0.02%
947,665
+233,937
+33% +$6.85M
FCX icon
755
PUT
Freeport-McMoran
FCX
$90B
$26.4M 0.02%
2,763,300
+1,361,200
+97% +$14M
ELAN icon
756
Elanco Animal Health
ELAN
$13.2B
$26.3M 0.02%
990,636
+128,742
+15% +$3.86M
JNJ icon
757
CALL
Johnson & Johnson
JNJ
$618B
$26.3M 0.02%
202,900
-53,400
-21% -$7.04M
BR icon
758
Broadridge
BR
$17.8B
$26.1M 0.02%
210,113
-47,190
-18% -$6.08M
MOMO
759
Hello Group
MOMO
$885M
$26.1M 0.02%
842,793
+233,563
+38% +$7.93M
EVH icon
760
Evolent Health
EVH
$348M
$26M 0.02%
3,617,293
+363,414
+11% +$2.61M
CZR icon
761
Caesars Entertainment
CZR
$6.06B
$26M 0.02%
652,109
+583,928
+856% +$24.8M
NUE icon
762
Nucor
NUE
$58.6B
$26M 0.02%
510,655
-211,913
-29% -$11.1M
FFIV icon
763
F5
FFIV
$22.9B
$25.9M 0.02%
184,178
+18,290
+11% +$2.53M
HOLX
764
DELISTED
Hologic
HOLX
$25.8M 0.02%
510,477
-29,836
-6% -$1.47M
AAL icon
765
PUT
American Airlines Group
AAL
$10.1B
$25.8M 0.02%
955,200
+259,700
+37% +$7.6M
CHRW icon
766
C.H. Robinson
CHRW
$17.4B
$25.7M 0.02%
303,459
-60,402
-17% -$5.08M
COR icon
767
Cencora
COR
$60.6B
$25.7M 0.02%
312,244
+54,425
+21% +$4.68M
SRPT icon
768
Sarepta Therapeutics
SRPT
$1.57B
$25.7M 0.02%
340,630
+66,697
+24% +$7.88M
NVRO
769
DELISTED
NEVRO CORP.
NVRO
$25.6M 0.02%
298,309
-250,036
-46% -$18.9M
ULTA icon
770
Ulta Beauty
ULTA
$22B
$25.5M 0.02%
101,849
+6,896
+7% +$2.12M
KSU
771
DELISTED
Kansas City Southern
KSU
$25.5M 0.02%
191,869
-52,798
-22% -$6.58M
OPTU
772
Optimum Communications Inc
OPTU
$298M
$25.5M 0.02%
887,775
-1,419,090
-62% -$38.6M
SSNC icon
773
SS&C Technologies
SSNC
$18.6B
$25.4M 0.02%
493,177
+270,577
+122% +$13.8M
LEG icon
774
Leggett & Platt
LEG
$1.34B
$25.3M 0.02%
618,538
+47,943
+8% +$1.88M
STOR
775
DELISTED
STORE Capital Corporation
STOR
$25.3M 0.02%
676,245
+203,762
+43% +$7.3M

Similar funds

Credit Suisse's Q3 2019 Portfolio in Review

As of Q3 2019, Credit Suisse held 4,406 positions worth $119B, up 5% from $113B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Credit Suisse deployed $6.41B of net new capital in Q3 2019, opening 331 new positions and adding to 2,055 existing holdings. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 11% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Genesee & Wyoming Inc., an estimated $312M trimmed.

  • Credit Suisse's largest Q3 2019 buy was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.
  • Credit Suisse added most to Allergan plc in Q3 2019, an estimated $1.02B increase.
  • Credit Suisse's biggest Q3 2019 reduction was Genesee & Wyoming Inc., cutting an estimated $312M.
  • Credit Suisse fully exited Anadarko Petroleum in Q3 2019, selling an estimated $331M.
  • Credit Suisse's ten largest holdings make up 16% of its $119B portfolio in Q3 2019.
  • Credit Suisse opened 331 new positions and closed 309 in Q3 2019.
  • Credit Suisse's portfolio value rose 5% quarter-over-quarter to $119B.

Based on Credit Suisse's 13F filing for Q3 2019, filed 12 Nov 2019.